Investing RAD receives IND approval from US FDA for Betabart (RV-01) July 28, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Asara raises $25m to accelerate exploration at Kada July 28, 2025 Next Post S&P 500 Breaking Out Again: What This Means for Your Portfolio July 28, 2025 Related Posts Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Completion of Silver Acquisition & Appointment of New Managing Director July 28, 2025 Asara raises $25m to accelerate exploration at Kada July 28, 2025
